x

Coronavirus

BioNTech Hopes for 12-15 Year Olds to Receive COVID-19 Vaccine from June

BERLIN — German pharmaceutical company BioNTech says it expects to receive the results of trials of its coronavirus vaccine in younger children by September.

BioNTech, which developed the first widely approved COVID-19 shot with U.S. partner Pfizer, has already submitted data from trials in children ages 12-15 to the U.S. Food and Drug Administration and plans to do so for the European Medicines Agency, which regulates drugs for use in the 27-nation European Union. .

The company said it expects results from trials in children ages 5-12 “as early as July” and in those younger than 5 in September.

BioNTech said requests for regulatory approval would depend on the results of the trials.

The company is one of the main suppliers of coronavirus vaccines in Europe and North America.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.